List of Excipients in API diazoxide
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing diazoxide
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA Inc | PROGLYCEM | diazoxide | 0575-6200 | ALCOHOL | |
| Teva Pharmaceuticals USA Inc | PROGLYCEM | diazoxide | 0575-6200 | CARBOXYMETHYLCELLULOSE SODIUM | |
| Teva Pharmaceuticals USA Inc | PROGLYCEM | diazoxide | 0575-6200 | HYDROCHLORIC ACID | |
| Teva Pharmaceuticals USA Inc | PROGLYCEM | diazoxide | 0575-6200 | MAGNESIUM ALUMINUM SILICATE | |
| Teva Pharmaceuticals USA Inc | PROGLYCEM | diazoxide | 0575-6200 | METHYLPARABEN | |
| Teva Pharmaceuticals USA Inc | PROGLYCEM | diazoxide | 0575-6200 | POLOXAMER 188 | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Showing 1 to 6 of 6 entries
Excipients in ANDA-approved (generic) drugs containing diazoxide
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Endo USA Inc | diazoxide | 0254-1010 | ALCOHOL |
| Endo USA Inc | diazoxide | 0254-1010 | CARBOXYMETHYLCELLULOSE SODIUM |
| Endo USA Inc | diazoxide | 0254-1010 | FD&C RED NO. 40 |
| Endo USA Inc | diazoxide | 0254-1010 | FD&C YELLOW NO. 6 |
| Endo USA Inc | diazoxide | 0254-1010 | HYDROCHLORIC ACID |
| Endo USA Inc | diazoxide | 0254-1010 | MAGNESIUM ALUMINUM SILICATE |
| >Company | >Ingredient | >NDC | >Excipient |
Showing 1 to 6 of 6 entries
Detailed excipient profiles for diazoxide
Excipient focus: ALCOHOL
diazoxide drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | diazoxide | 0254-1010 |
| Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
| e5 Pharma LLC | diazoxide | 13517-100 |
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
diazoxide drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
diazoxide drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | diazoxide | 0254-1010 |
| Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
| e5 Pharma LLC | diazoxide | 13517-100 |
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
diazoxide drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: FD&C RED NO. 40
diazoxide drug variants containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | diazoxide | 0254-1010 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
diazoxide drug variants not containing FD&C RED NO. 40
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
| e5 Pharma LLC | diazoxide | 13517-100 |
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
Excipient focus: FD&C YELLOW NO. 6
diazoxide drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | diazoxide | 0254-1010 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
diazoxide drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
| e5 Pharma LLC | diazoxide | 13517-100 |
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
Excipient focus: HYDROCHLORIC ACID
diazoxide drug variants containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | diazoxide | 0254-1010 |
| Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
| e5 Pharma LLC | diazoxide | 13517-100 |
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
diazoxide drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: MAGNESIUM ALUMINUM SILICATE
diazoxide drug variants containing MAGNESIUM ALUMINUM SILICATE
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | diazoxide | 0254-1010 |
| Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
| e5 Pharma LLC | diazoxide | 13517-100 |
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
diazoxide drug variants not containing MAGNESIUM ALUMINUM SILICATE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: METHYLPARABEN
diazoxide drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | diazoxide | 0254-1010 |
| Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
| e5 Pharma LLC | diazoxide | 13517-100 |
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
diazoxide drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: POLOXAMER 188
diazoxide drug variants containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | diazoxide | 0254-1010 |
| Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
| e5 Pharma LLC | diazoxide | 13517-100 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
diazoxide drug variants not containing POLOXAMER 188
| Company | Ingredient | NDC |
|---|---|---|
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
Excipient focus: PROPYLENE GLYCOL
diazoxide drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | diazoxide | 0254-1010 |
| Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
| e5 Pharma LLC | diazoxide | 13517-100 |
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
diazoxide drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: PROPYLENE OXIDE
diazoxide drug variants containing PROPYLENE OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
diazoxide drug variants not containing PROPYLENE OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | diazoxide | 0254-1010 |
| Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
| e5 Pharma LLC | diazoxide | 13517-100 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
Excipient focus: PROPYLPARABEN
diazoxide drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | diazoxide | 0254-1010 |
| Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
| e5 Pharma LLC | diazoxide | 13517-100 |
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
diazoxide drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: SODIUM BENZOATE
diazoxide drug variants containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | diazoxide | 0254-1010 |
| Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
| e5 Pharma LLC | diazoxide | 13517-100 |
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
Showing 1 to 4 of 4 entries
diazoxide drug variants not containing SODIUM BENZOATE
| Company | Ingredient | NDC |
|---|---|---|
| No data available in table | ||
| >Company | >Ingredient | >NDC |
Showing 0 to 0 of 0 entries
Excipient focus: SODIUM HYDROXIDE
diazoxide drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
| e5 Pharma LLC | diazoxide | 13517-100 |
| >Company | >Ingredient | >NDC |
Showing 1 to 2 of 2 entries
diazoxide drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | diazoxide | 0254-1010 |
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
Showing 1 to 2 of 2 entries
Excipient focus: SORBITOL
diazoxide drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | diazoxide | 0254-1010 |
| Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
| e5 Pharma LLC | diazoxide | 13517-100 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
diazoxide drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
Excipient focus: SORBITOL SOLUTION 70%
diazoxide drug variants containing SORBITOL SOLUTION 70%
| Company | Ingredient | NDC |
|---|---|---|
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
diazoxide drug variants not containing SORBITOL SOLUTION 70%
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | diazoxide | 0254-1010 |
| Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
| e5 Pharma LLC | diazoxide | 13517-100 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
Excipient focus: WATER
diazoxide drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Endo USA Inc | diazoxide | 0254-1010 |
| Teva Pharmaceuticals USA Inc | diazoxide | 0575-6200 |
| e5 Pharma LLC | diazoxide | 13517-100 |
| >Company | >Ingredient | >NDC |
Showing 1 to 3 of 3 entries
diazoxide drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| TriRx Huntsville Pharmaceutical Services LLC | diazoxide oral suspension | 80432-057 |
| >Company | >Ingredient | >NDC |
Showing 1 to 1 of 1 entries
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
